BioMarin Pharmaceutical D
D
BMRN
61.980
USD
-0.70
(-1.12%)
مغلق
حجم التداول
96,041
الربح لكل سهم
4
العائد الربحي
-
P/E
28
حجم السوق
11,884,923,457
الأخبار المقالات
العنوان: BioMarin Pharmaceutical
القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.